jain.com
The Analysis · Companies · People · Methodology

ChronoScale Legacy Ekso divestment commitment

Company: Applied Digital

This claim was marked delayed on September 1, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
acquisition
Statement date
2026-07-28
Promised by
2026-06-04
Current status
delayed

The claim, verbatim

On June 4, 2026, ChronoScale Board committed to plan to divest Legacy Ekso Bionics business and focus solely on cloud business; Legacy Ekso business designated as held for sale

Source (primary)

Applied Digital 10-K filed 2026-07-29 (SEC EDGAR, sec_filing)
View cached copy (2026-08-30)Live source ↗

Quote: “On June 4, 2026, ChronoScale announced that its Board of Directors committed to a plan to divest the Legacy Ekso business and to focus its operations solely on its cloud business. As such, the Legacy Ekso business was designated as "held for sale."”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms Applied Digital 10-K filed 2026-07-29

Quote: “On June 4, 2026, ChronoScale announced that its Board of Directors committed to a plan to divest the Legacy Ekso business and to focus its operations solely on its cloud business. As such, the Legacy Ekso business was designated as "held for sale."”

View cached copy (2026-08-30)Live source ↗

Record of changes

August 31, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 1, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.